China Pharma (NYSE:CPHI) Now Covered by Analysts at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research report issued on Wednesday. The brokerage set a “hold” rating on the stock.

China Pharma Price Performance

NYSE:CPHI opened at $0.24 on Wednesday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.26 and a current ratio of 0.79. The firm has a 50-day moving average price of $0.21 and a two-hundred day moving average price of $0.22. China Pharma has a twelve month low of $0.13 and a twelve month high of $0.60.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.